Pfizer Inc PFE
Revenue Intelligence Report • 58 quarters of SEC filing data • Updated 2026-03-15
Pfizer Inc has a forecasted full-year revenue of $48B, a -23.2% year-over-year change, based on 58 quarters of SEC filing data. Key revenue drivers include SG&A (elasticity 0.14x). The ARDL model has 25.6% MAPE.
Investment Thesis
At 25.6% MAPE, the model captures Pfizer Inc's broad revenue trajectory, though quarterly variability suggests sensitivity to external factors. Sales & marketing spend shows a 0.14x elasticity, suggesting effective go-to-market execution.
Next FY Revenue
$48.1B
-23.2% YoY
SG&A Elasticity
0.14x
Model Accuracy
25.6% MAPE
Holdout validation: The model predicted $11B vs the actual $18B — an error of 36.9%.
Note:
Pfizer Inc does not report R&D expenses separately. This analysis uses SG&A spending only.
Investor insight:
Actual revenue ($18B) came in 37% above the spending-based forecast ($11B). This suggests that Pfizer Inc's recent revenue growth is driven significantly by external demand factors — such as market pricing, product cycle tailwinds, or structural demand shifts — beyond what its R&D and SG&A spending alone would predict.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $11B | $18B | $5.7B – $22B | -37.7% | ✓ In range |
| Q1 2026 | $13B | $5.1B – $34B | -4.0% | ||
| Q2 2026 | $11B | $3.6B – $36B | -21.6% | ||
| Q3 2026 | $13B | $3.4B – $49B | -21.7% | ||
| Q4 2026 | $10B | $2.4B – $46B | -40.8% |
Seasonal Factors
Multiplicative seasonal adjustment:
These factors capture Pfizer Inc's systematic quarterly revenue patterns relative to the trend model.
A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below.
Factors are computed as the median of (actual / fitted) across all available quarters.
| Fiscal Quarter | Seasonal Factor | vs Trend | Interpretation | Obs. |
|---|---|---|---|---|
| FQ1 (Sep–Nov) | 1.0078 | +0.8% | In line with trend | 14 |
| FQ2 (Dec–Feb) | 0.8793 | -12.1% | -12.1% below trend | 13 |
| FQ3 (Mar–May) | 1.1331 | +13.3% | +13.3% above trend | 13 |
| FQ4 (Jun–Aug) | 1.0528 | +5.3% | +5.3% above trend | 14 |
How Spending Drives Revenue
Reading this chart:
Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch